Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JHY, Alger HM, Wong SS, Muntner P, On behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2017) Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135:e146–e603
2. Visser SAG, de Alwis DP, Kerbusch T, Stone JA, Allerheiligen SRB (2014) Implementation of quantitative and systems pharmacology in large pharma. CPT 3:1–10
3. Rajman I (2008) PK/PD modelling and simulations: utility in drug development. Drug Discov Today 13(7–8):341–346
4. Deshmukh R (2012) Modeling and simulation in drug discovery and development. J Bioequiv Availab 4(6):27–28
5. Bueters T, Gibson C, Visser SA (2015) Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery. Future Med Chem 7(17):2351–2369
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献